Clinical Trial Update: Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders [Phase 4]

View source ↗

Summary

A Phase 4 trial update comparing GnRH agonist versus estrogen and progesterone for luteal support in high responders undergoing fertility treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome
• Pregnancy Loss

Drugs mentioned

• Estrogen and Progesterone luteal support (estrogen and progesterone)
• Gonadotropin-releasing hormone agonist

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Pregnancy Early, Miscarriage | Phase 4 | Status: UNKNOWN